Under it, a Common Drug Review recommends toprovincial lists which new drugs should be included, predictablyand regrettablyQuebec refused to join.

• 在这个办公室下有一个普通药物评估机构,它向各省推荐应该在清单上增加的新药。不出所料,遗憾的是魁北克省拒绝加入这个机构。